SAN ANTONIO BREAST CANCER SYMPOSIUM-37TH ANNUAL SYMPOSIUM SAN ANTONIO, TEXAS, USA - DECEMBER 9-13, 2014

被引：0

作者：

Chan, D. ^{[1
]}

机构：

[1] Thomson Reuters, London, England

来源：

DRUGS OF THE FUTURE | 2015年 / 40卷 / 02期

关键词：

Trastuzumab; Lucitanib; Talazoparib; Palbociclib; Buparlisisb; Pertuzumab; Taselisib;

D O I：

10.1358/dof.2015.040.02.2297179

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The 37th Annual Meeting, presented by the Cancer Therapy and Research Center at UT Health Science Center San Antonio, the American Association for Cancer Research and Baylor College of Medicine, hosted close to 8,000 attendees from more than 90 countries. Attendees had the opportunity to hear the latest developments in breast cancer research in the many oral sessions and poster presentations. The symposium had the objective to provide state-of-the-art information on all aspects of breast cancer research, therapy and disease to an audience of physicians and scientists from academia and the pharmaceutical industry.

引用

页码：139 / 143

页数：5